» Articles » PMID: 23963445

Structure-activity Studies of 4-phenyl-substituted 2'-benzoylpyridine Thiosemicarbazones with Potent and Selective Anti-tumour Activity

Overview
Journal Org Biomol Chem
Specialties Biochemistry
Chemistry
Date 2013 Aug 22
PMID 23963445
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

2'-Benzoylpyridine thiosemicarbazones (BpT) are effective iron chelators and display potent anti-proliferative activity against tumour cells. In order to gain greater insight into the structure-activity relationships of the BpT chelators, ten new analogues containing phenyl substituents at the N4-position of the BpT structure were synthesised. Importantly, aromatic substitution at the latter position of the BpT scaffold has not been previously explored and these studies represent the first attempt to investigate their structure-activity relationships. These compounds demonstrated significantly enhanced anti-proliferative activity compared to the clinically used iron chelator, desferrioxamine (DFO). Furthermore, the compounds showed appreciable therapeutic indices against cancer cells over normal cells in vitro. Structure-activity analysis revealed that electron-donating substituents such as -CH3 and -OCH3 resulted in greater anti-proliferative activity than electron-withdrawing groups such as -Br and -Cl. These findings help to elucidate the effect of a variety of 4-phenyl substituents on the biological activity of BpT series of chelators and facilitate the future development of thiosemicarbazones with improved anti-tumour activity.

Citing Articles

Novel Copper(II) Coordination Compounds Containing Pyridine Derivatives of -Methoxyphenyl-Thiosemicarbazones with Selective Anticancer Activity.

Rusnac R, Garbuz O, Kravtsov V, Melnic E, Istrati D, Tsapkov V Molecules. 2025; 29(24.

PMID: 39770091 PMC: 11676775. DOI: 10.3390/molecules29246002.


Differential transmetallation of complexes of the anti-cancer thiosemicarbazone, Dp4e4mT: effects on anti-proliferative efficacy, redox activity, oxy-myoglobin and oxy-hemoglobin oxidation.

Dharmasivam M, Kaya B, Wijesinghe T, Richardson V, Harmer J, Gonzalvez M Chem Sci. 2024; 15(3):974-990.

PMID: 38239703 PMC: 10793205. DOI: 10.1039/d3sc05723b.


Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation.

Greene C, Sharma N, Fiorica P, Forrester E, Smith G, Gross K Free Radic Biol Med. 2018; 133:295-309.

PMID: 30553971 PMC: 10038186. DOI: 10.1016/j.freeradbiomed.2018.12.013.


Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy.

Malik M, Dar O, Gull P, Wani M, Hashmi A Medchemcomm. 2018; 9(3):409-436.

PMID: 30108933 PMC: 6071736. DOI: 10.1039/c7md00526a.


Crystal structure of 1-(4-methyl-phen-yl)-3-(propan-2-yl-idene-amino)-thio-urea.

Jotani M, Yeo C, Tiekink E Acta Crystallogr E Crystallogr Commun. 2015; 71(Pt 10):1236-41.

PMID: 26594415 PMC: 4647415. DOI: 10.1107/S2056989015017624.